1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.032235-0
2011-11-01
2024-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/11/1708.html?itemId=/content/journal/jmm/10.1099/jmm.0.032235-0&mimeType=html&fmt=ahah

References

  1. Bachmann S. P., VandeWalle K., Ramage G., Patterson T. F., Wickes B. L., Graybill J. R., López-Ribot J. L. 2002; In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46:3591–3596 [View Article][PubMed]
    [Google Scholar]
  2. Bassetti M., Righi E., Costa A., Fasce R., Molinari M. P., Rosso R., Pallavicini F. B., Viscoli C. 2006; Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21 [View Article][PubMed]
    [Google Scholar]
  3. Bizerra F. C., Melo A. S., Katchburian E., Freymüller E., Straus A. H., Takahashi H. K., Colombo A. L. 2011; Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. Antimicrob Agents Chemother 55:302–310 [View Article][PubMed]
    [Google Scholar]
  4. Chamilos G., Lewis R. E., Albert N., Kontoyiannis D. P. 2007; Paradoxical effect of echinocandins across Candida species in vitro: evidence for echinocandin-specific and Candida species-related differences. Antimicrob Agents Chemother 51:2257–2259 [View Article][PubMed]
    [Google Scholar]
  5. Choi H. W., Shin J. H., Jung S. I., Park K. H., Cho D., Kee S. J., Shin M. G., Suh S. P., Ryang D. W. 2007; Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob Agents Chemother 51:1520–1523 [View Article][PubMed]
    [Google Scholar]
  6. Cocuaud C., Rodier M. H., Daniault G., Imbert C. 2005; Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56:507–512 [View Article][PubMed]
    [Google Scholar]
  7. Ferreira J. A., Carr J. H., Starling C. E., de Resende M. A., Donlan R. M. 2009; Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother 53:4377–4384 [View Article][PubMed]
    [Google Scholar]
  8. Fleischhacker M., Radecke C., Schulz B., Ruhnke M. 2008; Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. Eur J Clin Microbiol Infect Dis 27:127–131 [View Article][PubMed]
    [Google Scholar]
  9. Garcia-Effron G., Park S., Perlin D. S. 2009; Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53:112–122 [View Article][PubMed]
    [Google Scholar]
  10. Jacobson M. J., Piper K. E., Nguyen G., Steckelberg J. M., Patel R. 2008; In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob Agents Chemother 52:2242–2243 [View Article][PubMed]
    [Google Scholar]
  11. Jacobson M. J., Steckelberg K. E., Piper K. E., Steckelberg J. M., Patel R. 2009; In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrob Agents Chemother 53:2638–2639 [View Article][PubMed]
    [Google Scholar]
  12. Kuhn D. M., George T., Chandra J., Mukherjee P. K., Ghannoum M. A. 2002; Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46:1773–1780 [View Article][PubMed]
    [Google Scholar]
  13. Melo A. S., Colombo A. L., Arthington-Skaggs B. A. 2007; Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 51:3081–3088 [View Article][PubMed]
    [Google Scholar]
  14. Miceli M. H., Bernardo S. M., Lee S. A. 2009a; In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Int J Antimicrob Agents 34:326–332 [View Article][PubMed]
    [Google Scholar]
  15. Miceli M. H., Bernardo S. M., Lee S. A. 2009b; In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms. Int J Antimicrob Agents 34:500–502 [View Article][PubMed]
    [Google Scholar]
  16. Nucci M., Queiroz-Telles F., Tobón A. M., Restrepo A., Colombo A. L. 2010; Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 51:561–570 [View Article][PubMed]
    [Google Scholar]
  17. Odabasi Z., Paetznick V., Rex J. H., Ostrosky-Zeichner L. 2007; Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother 51:4214–4216 [View Article][PubMed]
    [Google Scholar]
  18. Pfaller M. A., Boyken L., Hollis R. J., Kroeger J., Messer S. A., Tendolkar S., Diekema D. J. 2008; In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46:150–156 [View Article][PubMed]
    [Google Scholar]
  19. Ramage G., López-Ribot J. L. 2005; Techniques for antifungal susceptibility testing of Candida albicans biofilms. Methods Mol Med 118:71–79[PubMed]
    [Google Scholar]
  20. Stevens D. A., Espiritu M., Parmar R. 2004; Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48:3407–3411 [View Article][PubMed]
    [Google Scholar]
  21. Tan T. Y., Tan A. L., Tee N. W., Ng L. S., Chee C. W. 2010; The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Mycoses 53:515–521 [View Article][PubMed]
    [Google Scholar]
  22. Wiederhold N. P., Grabinski J. L., Garcia-Effron G., Perlin D. S., Lee S. A. 2008; Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrob Agents Chemother 52:4145–4148 [View Article][PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.032235-0
Loading
/content/journal/jmm/10.1099/jmm.0.032235-0
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error